Inflammation as a central mechanism in Alzheimer's disease

Prince M., 2016, World Alzheimer Report 2016: Improving Healthcare for People Living With Dementia: Coverage, Quality and Costs Now and in the Future

10.1212/WNL.0b013e31828726f5

Alzheimer's Impact Movement, 2017, Alzheimer's Disease Caregivers Factsheet

10.1146/annurev.ne.17.030194.002421

10.1146/annurev-neuro-061010-113613

10.1111/j.1471-4159.1992.tb10128.x

10.1006/nbdi.2000.0321

10.1073/pnas.90.5.2092

Butterfield D.A., 2012, Amyloid β‐Peptide (1–42)‐Induced oxidative stress in Alzheimer disease: Importance in disease pathogenesis and progression, Antioxid Redox Signal, 19, 823, 10.1089/ars.2012.5027

10.1038/359322a0

10.1074/jbc.M402034200

10.3233/JAD-2010-1221

10.1159/000369101

10.1016/0166-2236(93)90008-A

10.1126/science.1439760

10.1007/s00018-008-8271-3

10.1097/00005072-199908000-00001

10.1038/nm0796-783

10.1073/pnas.91.12.5562

10.1073/pnas.94.1.298

10.1016/0006-8993(89)91396-6

10.1016/S0079-6123(08)64021-2

10.1016/S0140-6736(86)92134-3

10.2174/156720510793611592

10.1016/S0021-9258(20)80536-5

10.1016/0006-8993(77)90155-X

10.1073/pnas.72.5.1858

10.1152/physrev.00024.2003

10.1083/jcb.143.3.777

10.2174/092986708785909111

10.1007/s00401-017-1707-9

10.4161/pri.1.1.4055

Šimić G., 2016, Tau Protein Hyperphosphorylation and aggregation in Alzheimer's disease and other tauopathies, and possible neuroprotective strategies, Biomolecules, 6, 10.3390/biom6010006

10.1186/s13195-016-0207-9

10.1126/science.1072994

Morris G.P., 2014, Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease, Acta Neuropathol Commun, 2

10.1001/archneur.60.5.729

10.1097/NEN.0b013e31825018f7

10.1097/NEN.0b013e3181919a48

10.1074/jbc.275.11.7918

10.1016/S0197-4580(00)00124-X

10.1523/JNEUROSCI.20-02-00558.2000

10.1073/pnas.86.19.7611

10.1097/00005072-199503000-00014

10.1017/S0317167100029863

10.1016/0165-0173(95)00011-9

10.1097/nen.0b013e31812503e1

10.1016/0046-8177(95)90001-2

10.1016/j.biocel.2004.07.009

10.1002/pnp.444

10.1186/1742-2094-9-179

Gomez‐Nicola D., 2015, Post‐mortem analysis of neuroinflammatory changes in human Alzheimer's disease, Alzheimers Res Ther, 7, 10.1186/s13195-015-0126-1

10.1016/j.neurobiolaging.2012.09.012

10.1016/j.bbadis.2015.11.011

10.1016/j.pnpbp.2017.05.007

10.1007/s00702-017-1731-x

10.1186/1742-2094-11-120

10.1016/j.jalz.2013.12.010

10.1186/1742-2094-8-26

Meraz‐Ríos M.A., 2013, Inflammatory process in Alzheimer's Disease, Front Integr Neurosci, 7

Rubio‐Perez J.M., 2012, A Review: Inflammatory process in Alzheimer's disease, role of cytokines, ScientificWorldJournal, 2012

Herrero M.‐T., 2015, Inflammation in Parkinson's disease: role of glucocorticoids, Front Neuroanat, 9

10.1186/s40035-015-0042-0

10.1016/j.it.2015.04.007

Ellrichmann G., 2013, The role of the immune system in Huntington's disease, Clin Dev Immunol, 2013, 10.1155/2013/541259

Silajdžić E., 2013, A critical evaluation of inflammatory markers in Huntington's Disease plasma, J Huntington's Dis, 2, 125, 10.3233/JHD-130049

Breunig J., 2013, Brain injury, neuroinflammation and Alzheimer's disease, Front Aging Neurosci, 5, 10.3389/fnagi.2013.00026

10.1007/s13311-014-0319-5

10.1016/j.mcn.2015.03.012

10.2174/156652411795243450

10.3892/mmr.2016.4948

10.1111/imm.12233

10.1111/j.1365-2567.2009.03225.x

Cappellano G., 2013, Immunity and inflammation in neurodegenerative diseases, Am J Neurodegenerative Dis, 2, 89

10.1016/j.cell.2010.02.016

10.1093/ajcn/83.2.470S

10.1073/pnas.162350199

10.1038/cddis.2011.50

10.1523/JNEUROSCI.2868-05.2005

10.1196/annals.1332.006

10.1523/JNEUROSCI.1071-09.2009

10.1007/s00401-014-1371-2

10.1073/pnas.0905529106

10.1016/S0197-4580(88)80079-4

10.4065/73.10.951

10.1212/WNL.44.2.227

10.1212/WNL.45.1.51

10.1016/j.neurobiolaging.2006.03.013

10.1007/s40266-015-0239-z

10.1212/WNL.42.2.447

10.1186/alzrt24

10.1038/emm.2006.40

10.1073/pnas.86.19.7606

10.1212/WNL.55.8.1158

10.1016/j.yexcr.2004.01.002

Sarma J.D., 2014, Microglia‐mediated neuroinflammation is an amplifier of virus‐induced neuropathology, J NeuroVirology, 20, 122, 10.1007/s13365-013-0188-4

10.1016/0361-9230(89)90018-X

Glenn J.A., 1992, Characterisation of ramified microglial cells: detailed morphology, morphological plasticity and proliferative capability, J Anat, 180, 109

10.1038/nn1472

10.1007/s11481-013-9434-z

10.1016/0306-4522(96)00106-6

10.1074/jbc.R115.637157

10.1016/j.tins.2007.07.007

10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J

10.1016/S0165-5728(03)00009-2

10.1002/jnr.10253

10.1073/pnas.95.18.10896

10.1523/JNEUROSCI.4814-07.2008

10.1002/cne.902110407

10.1016/0304-3940(88)90585-X

Mrak R.E., 2012, Microglia in Alzheimer Brain: A neuropathological perspective, Int J Alzheimer's Dis

10.1002/glia.23074

10.1016/S0002-9440(10)65423-5

10.1038/78682

10.1016/j.neuron.2006.01.022

10.1074/jbc.M110.149468

10.1074/jbc.M111.324616

10.1523/JNEUROSCI.0616-08.2008

10.1096/fj.09-141754

10.1172/JCI31450

10.1038/374647a0

10.1097/00005072-199807000-00008

10.1371/journal.pone.0060921

10.1016/j.jneuroim.2009.02.003

Bhaskar K., 2014, Microglial derived tumor necrosis factor‐α drives Alzheimer's disease‐related neuronal cell cycle events, Neurobiol Dis, 62, 10.1016/j.nbd.2013.10.007

10.1016/j.brainresbull.2011.10.004

10.1046/j.1471-4159.2000.0741017.x

10.1002/ana.410100605

10.1084/jem.20142322

Bemiller S.M., 2017, TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy, Mol Neurodegener, 12, 10.1186/s13024-017-0216-6

10.1523/JNEUROSCI.4586-14.2015

10.1016/j.cell.2015.01.049

10.1056/NEJMoa1211851

10.1016/j.bcp.2013.11.021

Jin S.C., 2015, TREM2 is associated with increased risk for Alzheimer's disease in African Americans, Mol Neurodegener, 10

10.1056/NEJMoa1211103

10.1084/jem.20030027

10.1086/342259

10.1038/77153

10.1111/j.1440-1789.2010.01127.x

10.1212/WNL.33.1.81

10.1111/j.1460-9568.2004.03729.x

10.1212/WNL.43.8.1467

10.1126/science.8346443

Ulrich J.D., 2014, Altered microglial response to A beta plaques in APPPS1‐21 mice heterozygous for TREM2, Mol Neurodegener, 9, 10.1186/1750-1326-9-20

10.1523/JNEUROSCI.2110-16.2016

10.3233/JAD-161277

10.1038/nn.4126

10.3233/JAD-130854

10.1186/1750-1326-9-20

10.1084/jem.20151948

10.1016/j.neuron.2016.05.003

10.1007/s00401-015-1388-1

10.1172/JCI77983

10.1016/j.cell.2017.07.023

10.1186/s13024-017-0216-6

10.1073/pnas.1710311114

10.1016/j.cell.2017.05.018

10.1038/385640a0

10.1016/S1471-4906(01)02051-8

10.1098/rsob.130181

10.1182/blood-2008-07-170787

10.1172/JCI71307

10.4049/jimmunol.1300090

10.1038/nn1715

Fuhrmann M., 2010, Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease, Nat Publishing Group, 13, 411

10.2353/ajpath.2010.100265

10.1038/nn.3554

10.1016/S0014-5793(98)00583-3

10.1016/S0092-8674(00)80438-9

10.3389/fncel.2014.00229

10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V

10.1016/S0006-8993(03)02867-1

10.1128/MCB.20.11.4106-4114.2000

10.1016/j.neuron.2010.08.023

10.1016/j.neurobiolaging.2013.06.007

10.1016/j.neulet.2008.03.019

10.1074/jbc.M111.254268

10.1016/S1054-3589(10)58006-2

10.1016/j.cell.2015.12.056

10.1038/nm.3639

10.5607/en.2017.26.3.122

Li Y., 2016, Implications of GABAergic Neurotransmission in Alzheimer's disease, Front Aging Neurosci, 8

10.1038/ncomms5159

10.1016/j.neubiorev.2016.01.007

10.1002/glia.21087

10.1016/j.mcn.2003.10.023

10.1016/j.cnr.2006.09.004

10.1111/bph.13125

10.1113/jphysiol.2014.278754

Le Meur K., 2012, GABA release by hippocampal astrocytes, Front Comput Neurosci, 6, 10.3389/fncom.2012.00059

10.1016/0304-3940(91)90490-K

10.1016/S0197-4580(01)00291-3

10.3233/JAD-2009-0976

10.1523/JNEUROSCI.4580-03.2004

10.1083/jcb.200705042

10.1016/j.neurobiolaging.2008.10.012

Chang R., 2017, Tumor necrosis factor α Inhibition for Alzheimer's Disease, J Cent Nervous Syst Dis, 9

10.1523/JNEUROSCI.21-04-01179.2001

10.2353/ajpath.2007.060378

10.1002/jnr.20266

10.1159/000255051

10.1016/j.brainresrev.2008.07.003

Cacabelos R., 1994, Brain interleukin‐1 beta in Alzheimer's disease and vascular dementia, Methods Findings Exp Clin Pharmacol, 16, 141

Farrar W.L., 1987, Visualization and characterization of interleukin 1 receptors in brain, J Immunol, 139, 459, 10.4049/jimmunol.139.2.459

10.1073/pnas.89.21.10075

10.1016/S0024-3205(97)00936-3

10.1038/42257

10.1016/j.bbamcr.2011.01.034

10.1016/j.bbamcr.2016.03.018

10.1212/WNL.0000000000000665

10.1016/0304-3940(95)12192-7

10.1016/j.jneuroim.2015.04.014

10.1007/s00406-004-0558-2

10.1007/BF00571510

10.1016/S0169-328X(97)00356-2

10.1038/sj.onc.1209943

10.1073/pnas.94.6.2642

10.1096/fj.03-1378fje

10.1016/S0968-0896(02)00440-6

10.1172/JCI18162

10.1016/S0002-9440(10)63269-5

10.1016/S0165-5728(00)00404-5

10.1159/000474940

10.1016/j.neuron.2015.01.021

10.1016/j.neuron.2014.12.068

10.1038/sj.gene.6363964

10.1016/j.jns.2010.12.005

Chao C.C., 1994, Transforming growth factor beta in Alzheimer's disease, Clin Diagn Lab Immunol, 1, 109, 10.1128/cdli.1.1.109-110.1994

10.1016/S0002-9440(10)61105-4

10.1016/S0197-0186(01)00046-8

10.1007/s00441-011-1230-6

10.1007/s12603-010-0325-1

10.1016/j.exger.2004.07.007

10.1523/JNEUROSCI.3351-16.2017

10.1093/aje/kwf074

10.1136/bmj.322.7300.1447

10.1093/ije/20.Supplement_2.S28

10.1136/jnnp.74.7.857

Thakur M.K., 2012, Traumatic brain injury: A risk factor of Alzheimer's disease, Neurosci Biobehav Rev, 36, 1376, 10.1016/j.neubiorev.2012.02.013

Djordievic J., 2016, Traumatic brain injury as a risk factor for Alzheimer's disease: is inflammatory signaling a key player?, Curr Alzheimer Res, 13, 730, 10.2174/1567205013666160222110320

10.1007/s00259-005-1762-7

10.1016/j.nut.2010.07.021

10.1016/j.pneurobio.2013.06.004

10.2337/diabetes.53.2.474

10.1016/S1474-4422(05)70284-2

10.1016/j.ejphar.2008.02.049

10.1212/WNL.53.9.1937

10.1212/WNL.0b013e31822f0435

10.1371/journal.pone.0087095

10.1001/archneur.63.11.1551

10.1159/000324134

10.1172/JCI104130

Bonadonna R.C., 1991, Glucose metabolism in obesity and type 2 diabetes, Diabete & Metabolisme, 17, 112

10.3233/JAD-2005-8304

10.3233/JAD-2005-7107

Monte de S.M., 2001, Ethanol impairs insulin‐stimulated mitochondrial function in cerebellar granule neurons, Cell Mol Life Sci, 58, 1950, 10.1007/PL00000829

10.3233/JAD-2006-9102

10.1073/pnas.0809158106

Li W., 2017, Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker Aβ1‐42 in Alzheimer's Disease Neuroimaging Initiative participants, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 10, 94, 10.1016/j.dadm.2017.11.002

10.1126/science.7678183

10.1038/oby.2000.86

10.1161/01.ATV.0000248096.62495.73

10.1080/13813450802181047

10.1016/j.imlet.2008.02.002

10.1001/archneurol.2011.670

10.1016/j.biopsych.2010.06.012

10.1016/0165-5728(93)90027-V

10.1159/000097202

10.1016/j.physbeh.2012.05.015

Freeman L.R., 2011, Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet, J Cereb Blood Flow Metab, 32, 643, 10.1038/jcbfm.2011.168

10.1093/gerona/glt177

Perry V.H., 2014, Microglial priming in neurodegenerative disease, Nat Publishing Group, 10, 217

10.1186/s12974-015-0467-5

Ledo J.H., 2016, Cross talk between brain innate immunity and serotonin signaling underlies depressive‐like behavior induced by Alzheimer's amyloid‐ oligomers in mice, J Neurosci, 36, 12106, 10.1523/JNEUROSCI.1269-16.2016

10.1038/nrneurol.2012.263

10.1007/s12264-013-1422-z

10.1001/jama.1997.03550160069041

10.1016/j.immuni.2017.08.008

10.1001/jama.282.1.40